PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 167 filers reported holding PRECIGEN INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99,000 | +17.9% | 73,505 | -4.4% | 0.00% | – |
| Q2 2023 | $84,000 | +7.7% | 76,860 | -2.2% | 0.00% | – |
| Q1 2023 | $78,000 | -31.1% | 78,590 | -0.1% | 0.00% | – |
| Q4 2022 | $113,200 | -62.6% | 78,679 | -43.2% | 0.00% | -100.0% |
| Q3 2022 | $303,000 | +93.0% | 138,549 | -33.8% | 0.00% | – |
| Q2 2022 | $157,000 | 0.0% | 209,247 | +194.7% | 0.00% | – |
| Q1 2022 | $157,000 | -43.7% | 70,998 | +0.9% | 0.00% | -100.0% |
| Q4 2021 | $279,000 | -25.6% | 70,398 | -55.9% | 0.00% | 0.0% |
| Q3 2021 | $375,000 | -24.4% | 159,548 | -0.1% | 0.00% | 0.0% |
| Q2 2021 | $496,000 | +15.3% | 159,659 | +155.4% | 0.00% | 0.0% |
| Q1 2021 | $430,000 | -19.9% | 62,519 | +18.6% | 0.00% | -50.0% |
| Q4 2020 | $537,000 | +160.7% | 52,719 | -10.2% | 0.00% | +100.0% |
| Q3 2020 | $206,000 | -29.0% | 58,719 | +0.9% | 0.00% | -50.0% |
| Q2 2020 | $290,000 | +51.8% | 58,223 | +1.7% | 0.00% | +100.0% |
| Q1 2020 | $191,000 | – | 57,223 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |